Fuchu, Japan

Kazuo Kamei

This inventor holds 2 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1995-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Kamei. Retrieved from https://idiyas.com/inventor/kazuo-kamei-73jsxtdh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuo Kamei: Innovator in Cerebral Circulation

Introduction

Kazuo Kamei is a notable inventor based in Fuchu, Japan. He has made significant contributions to the field of cerebral circulation through his innovative patents. With a total of 2 patents, Kamei's work focuses on improving cerebral health.

Latest Patents

Kamei's latest patents include a method of ameliorating cerebral circulation. This invention features an ameliorant that contains 2-carbamoyloxymethyl-4-(2,3-dichlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3-isopropyl ester 5-methyl ester as an active ingredient. Another significant patent is the ameliorant of cerebral circulation and optical isomer of NB-818, which also utilizes the same active ingredient for enhancing cerebral circulation.

Career Highlights

Kazuo Kamei is associated with Banyu Pharmaceutical Co. Ltd., where he has been instrumental in developing innovative solutions for cerebral health. His work has garnered attention in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Kamei has collaborated with notable coworkers such as Masaru Nishikibe and Jun Nagura. Their combined efforts have led to significant advancements in their field.

Conclusion

Kazuo Kamei's contributions to cerebral circulation through his patents highlight his role as an innovator in the pharmaceutical industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…